Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Congenital neutropenia: a case study.

D Daghistani1, J J Jimenez, S R Toledano

  • 1Department of Pediatrics, University of Miami School of Medicine, Florida 33101.

The American Journal of Pediatric Hematology/Oncology
|January 1, 1990
PubMed
Summary

Infantile genetic agranulocytosis (IGA) involves severe neutropenia. Research suggests a G-CSF receptor defect, not a G-CSF deficiency, is the likely cause in IGA patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid volumetric rewarming of cryopreserved samples using a steerable ultrasound array.

Ultrasonics·2026
Same author

Monolithic integration of a 10 μm cut-off wavelength InAs/GaSb type-II superlattice diode on GaAs platform.

Scientific reports·2022
Same author

Bioinspired gelatin/bioceramic composites loaded with bone morphogenetic protein-2 (BMP-2) promote osteoporotic bone repair.

Biomaterials advances·2022
Same author

The Mars Environmental Dynamics Analyzer, MEDA. A Suite of Environmental Sensors for the Mars 2020 Mission.

Space science reviews·2021
Same author

Comment on "Global distribution of earthworm diversity".

Science (New York, N.Y.)·2021
Same author

Unravelling the polarity of InN quantum dots using a modified approach of negative-spherical-aberration imaging.

Nanoscale·2019

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Genetics

Background:

  • Infantile genetic agranulocytosis (IGA) presents with severe neutropenia, leading to high morbidity and mortality.
  • Pathogenetic mechanisms of IGA remain largely unknown.
  • Previous trials with recombinant human granulocyte-colony-stimulating factor (rhG-CSF) showed increased neutrophil counts, suggesting potential G-CSF pathway involvement.

Observation:

  • A clinical trial using recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in an infant with IGA resulted in a significant eosinophilic response.
  • No increase in absolute neutrophil count (ANC) was observed following rhGM-CSF administration.
  • In vitro studies assessed patient CFU-GM response to rhGM-CSF and rhG-CSF, and monocyte G-CSF production.

Findings:

  • Results indicate that the defect in IGA is likely at the G-CSF receptor level.
  • In vitro testing showed patient CFU-GM responded to rhG-CSF but not rhGM-CSF.
  • A lack of correlation was found between in vivo and in vitro responses to rhGM-CSF.

Implications:

  • These findings help elucidate the underlying pathogenetic mechanisms of infantile genetic agranulocytosis.
  • Understanding the G-CSF receptor defect could lead to more targeted therapeutic strategies for IGA.
  • Further research is warranted to explore the specific role of G-CSF receptor dysfunction in severe congenital neutropenias.

Related Experiment Videos